CT-388 and CT-868, developed by Carmot Therapeutics, are GIPR/GLP-1R agonists under investigation in obese patients, including those with type 1 diabetes (NCT04838405, NCT06062069)
The medication still works, but you have increased caloric intake to match the reduced metabolic expenditure from weight loss
What happens to appetite if you stop retatrutide This is a critical question that does not have definitive answers from retatrutide-specific studies yet, but data from semaglutide and tirzepatide trials provides relevant context
After my period that 35lbs magically disappears." Itsnotjustcheese Another user described an even larger swing: "I sometimes gain around 57 lbs starting a few days before Im supposed to start my period and lose it throughout the week." ObviousSurprise1888 And for some, the pattern is so consistent that its predictable: "I usually gain around my time of the month." anonymous These fluctuations can happen even while fat loss remains completely steady
Michael Lincoff, Kirstine Brown-Frandsen, Helen M